The deal marks Adenia’s first majority investment in Egypt and Admaius’s inaugural exit from its current fund.

EGYPT – Adenia Partners, a private equity firm focused on African growth opportunities, has signed definitive agreements to acquire a majority stake in Egypt’s Parkville Pharmaceuticals from Admaius Capital Partners and the company’s founders.
The transaction involves Admaius selling its full stake acquired in November 2023, while founders Dr. Sherif Bassiouny (Chairman) and Dr. Mahmoud Farrag (CEO) retain minority shares alongside Adenia.
It remains subject to regulatory approvals and customary closing conditions, with financial terms undisclosed.
Advisors included Zilla Capital for sellers, Matouk Bassiouny for legal support, and Baker McKenzie for Adenia.
Dr. Mahmoud Farrag, co-founder and CEO of Parkville Pharmaceuticals, said: “We are proud of the solid progress Parkville has achieved over the past two years in partnership with Admaius and our management team.¨
¨This transformation has delivered a highly positive outcome for Admaius, translating into strong value creation.¨
Founded in 2008 and based in Cairo, Parkville leads in Egypt’s pharmaceutical, cosmeceutical, and nutraceutical sectors, offering a wide range of health, beauty, and wellness products, including skin care, hair care, baby & kids supplements, body care, and cosmeceutical solutions.
Their portfolio spans treatment creams, cleansers, serums, sunscreens, multivitamins, and aesthetic products, all made in Egypt.
Under Admaius ownership, it boosted manufacturing, governance, exports, and e-commerce amid Egypt’s currency devaluation and inflation.
Adenia Partners taps into Egypt’s health and wellness market is valued at about USD 11.8 billion (2025) and is projected to grow steadily to USD 16.5 billion by 2034, driven by rising health awareness, urbanization, and demand for preventive healthcare, according to a report by IMARC.
The sector is diversifying rapidly, with growth in fitness centers, organic food, wellness tourism, and digital health platforms.
Meanwhile, mid-last year, Dislog Group significantly strengthened its beauty portfolio and market access in Morocco by acquiring 100% of the shares and voting rights of Avon Beauty Products SARLU, the Moroccan subsidiary of the global cosmetics leader Avon Cosmetics.
This deal marked a significant strategic move in Dislog’s expansion plan to consolidate its position as a leader in the Moroccan beauty market.
Sign up to receive our email newsletters with the latest news updates and insights from Africa and the World HERE.